RSCM

Rock Springs Capital Management Portfolio holdings

AUM $1.71B
1-Year Est. Return 43.68%
This Quarter Est. Return
1 Year Est. Return
+43.68%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.71B
AUM Growth
+$106M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
101
New
Increased
Reduced
Closed

Top Buys

1
+$11M
2
+$8.41M
3
+$7.09M
4
TVTX icon
Travere Therapeutics
TVTX
+$6.13M
5
MBX
MBX Biosciences
MBX
+$4.95M

Top Sells

1
+$43.9M
2
+$24.3M
3
+$23.8M
4
INSM icon
Insmed
INSM
+$20.2M
5
UNH icon
UnitedHealth
UNH
+$15.8M

Sector Composition

1 Healthcare 98.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EVH icon
26
Evolent Health
EVH
$469M
$25M 1.46%
2,950,000
+129,300
CAI
27
Caris Life Sciences
CAI
$7.2B
$24M 1.4%
793,651
CDTX icon
28
Cidara Therapeutics
CDTX
$6.91B
$23.9M 1.4%
249,402
+115,269
DXCM icon
29
DexCom
DXCM
$24.8B
$21.3M 1.25%
316,900
+30,150
OMDA
30
Omada Health Inc
OMDA
$1.08B
$20.3M 1.19%
919,950
-1
CLDX icon
31
Celldex Therapeutics
CLDX
$1.8B
$18.7M 1.09%
721,538
-91,115
VERA icon
32
Vera Therapeutics
VERA
$2.16B
$17.9M 1.05%
617,396
PHR icon
33
Phreesia
PHR
$1.23B
$17.6M 1.03%
749,116
-88,184
TARS icon
34
Tarsus Pharmaceuticals
TARS
$3.39B
$17.1M 1%
288,344
-85,406
NAMS icon
35
NewAmsterdam Pharma
NAMS
$4.68B
$16.9M 0.99%
595,929
+59,818
CMPX icon
36
Compass Therapeutics
CMPX
$1.03B
$15.7M 0.92%
4,474,702
-488,253
PHVS icon
37
Pharvaris
PHVS
$1.84B
$15.6M 0.91%
623,402
AZTA icon
38
Azenta
AZTA
$1.63B
$15.5M 0.91%
540,400
+10,000
MLYS icon
39
Mineralys Therapeutics
MLYS
$3.41B
$15.5M 0.9%
408,313
+83,800
FOLD icon
40
Amicus Therapeutics
FOLD
$3.06B
$15.3M 0.9%
1,947,374
-12,960
XBI icon
41
State Street SPDR S&P Biotech ETF
XBI
$8.17B
$15.2M 0.89%
151,750
ACLX icon
42
Arcellx
ACLX
$4.2B
$14.7M 0.86%
178,982
-7,332
SMMT icon
43
Summit Therapeutics
SMMT
$13.3B
$14.7M 0.86%
710,000
COGT icon
44
Cogent Biosciences
COGT
$6.17B
$14.5M 0.85%
1,008,308
+208,109
ELVN icon
45
Enliven Therapeutics
ELVN
$1.28B
$14M 0.82%
686,107
-15,301
ZBIO
46
Zenas BioPharma
ZBIO
$2.08B
$12.9M 0.75%
580,677
-59,790
NBIX icon
47
Neurocrine Biosciences
NBIX
$15.2B
$12.6M 0.74%
89,750
+950
ARDX icon
48
Ardelyx
ARDX
$1.41B
$12.6M 0.74%
2,286,273
DHR icon
49
Danaher
DHR
$160B
$12.2M 0.71%
61,500
+2,500
LENZ
50
LENZ Therapeutics
LENZ
$955M
$11M 0.64%
236,227
+152,245
1
2
3 4